Stoke Therapeutics, Inc. (STOK)
NASDAQ·Healthcare·Biotechnology
$33.49
-0.65%
Mkt Cap $2.11B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $5.83M | $1.40M | -75.97% | -$0.75 | -$0.97 | -29.33% | — | — |
| Q4 2025 Nov 4, 2025 | $4.56M | $10.63M | +133.39% | -$0.54 | -$0.65 | -20.37% | — | — |
| Q3 2025 Aug 12, 2025 | $5.36M | $13.82M | +157.99% | -$0.57 | -$0.40 | +29.82% | — | — |
| Q2 2025 May 13, 2025 | $31.51M | $158.57M | +403.19% | -$0.37 | $1.90 | +613.51% | — | — |
| Q1 2025 Mar 18, 2025 | $3.86M | $22.61M | +485.85% | -$0.51 | -$0.18 | +64.71% | — | — |
| Q4 2024 Nov 5, 2024 | $4.20M | $4.89M | +16.52% | -$0.52 | -$0.47 | +9.62% | — | — |
| Q3 2024 Aug 7, 2024 | $3.26M | $4.83M | +48.19% | -$0.57 | -$0.46 | +19.30% | — | — |
| Q2 2024 May 6, 2024 | $3.21M | $4.22M | +31.34% | -$0.60 | -$0.57 | +5.00% | — | — |
| Q1 2024 Mar 25, 2024 | $3.25M | $2.80M | -13.78% | -$0.62 | -$0.60 | +3.23% | — | — |
| Q4 2023 Nov 7, 2023 | $3.25M | $3.31M | +1.78% | -$0.65 | -$0.55 | +15.38% | — | — |
| Q3 2023 Aug 7, 2023 | $3.17M | $2.48M | -21.74% | -$0.65 | -$0.69 | -6.15% | — | — |
| Q2 2023 May 4, 2023 | $3.00M | $5.15M | +71.73% | -$0.70 | -$0.53 | +24.29% | — | — |
| Q1 2023 Mar 6, 2023 | $2.86M | $3.27M | +14.19% | -$0.72 | -$0.65 | +9.72% | — | — |
| Q4 2022 Nov 14, 2022 | $2.72M | $2.90M | +6.71% | -$0.69 | -$0.66 | +4.35% | — | — |
| Q3 2022 Aug 8, 2022 | $2.64M | $3.23M | +22.36% | -$0.70 | -$0.63 | +10.00% | — | — |
| Q2 2022 May 10, 2022 | $50.00M | $3.00M | -94.00% | $0.61 | -$0.66 | -208.20% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.62 | -$0.66 | -6.45% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.58 | -$0.61 | -5.17% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.49 | -$0.60 | -22.45% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.44 | -$0.46 | -4.55% | — | — |